News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
759,356 Results
Type
Article (51075)
Company Profile (299)
Press Release (707971)
Multimedia
Podcasts (95)
Webinars (17)
Section
Business (212829)
Career Advice (2115)
Deals (36652)
Drug Delivery (119)
Drug Development (83993)
Employer Resources (174)
FDA (17220)
Job Trends (15804)
News (360567)
Policy (34903)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2794)
Accelerated approval (31)
Adcomms (29)
Allergies (141)
Alliances (51760)
ALS (173)
Alzheimer's disease (1725)
Antibody-drug conjugate (ADC) (312)
Approvals (17482)
Artificial intelligence (533)
Autoimmune disease (150)
Automation (38)
Bankruptcy (374)
Best Places to Work (12096)
BIOSECURE Act (20)
Biosimilars (189)
Biotechnology (190)
Bladder cancer (159)
Brain cancer (58)
Breast cancer (649)
Cancer (4864)
Cardiovascular disease (416)
Career advice (1795)
Career pathing (38)
CAR-T (280)
CDC (49)
Celiac Disease (2)
Cell therapy (743)
Cervical cancer (38)
Clinical research (71491)
Collaboration (1727)
Company closure (4)
Compensation (1145)
Complete response letters (55)
COVID-19 (2837)
CRISPR (89)
C-suite (845)
Cystic fibrosis (144)
Data (6229)
Decentralized trials (2)
Denatured (35)
Depression (139)
Diabetes (509)
Diagnostics (6894)
Digital health (45)
Diversity (13)
Diversity, equity & inclusion (46)
Drug discovery (244)
Drug pricing (194)
Drug shortages (31)
Duchenne muscular dystrophy (228)
Earnings (92236)
Editorial (60)
Employer branding (21)
Employer resources (152)
Events (122348)
Executive appointments (988)
FDA (20380)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1488)
Gene editing (197)
Generative AI (49)
Gene therapy (595)
GLP-1 (1026)
Government (4938)
Grass and pollen (6)
Guidances (385)
Healthcare (19956)
HIV (57)
Huntington's disease (45)
IgA nephropathy (81)
Immunology and inflammation (252)
Immuno-oncology (54)
Indications (104)
Infectious disease (3106)
Inflammatory bowel disease (193)
Inflation Reduction Act (14)
Influenza (114)
Intellectual property (244)
Interviews (323)
IPO (17006)
IRA (50)
Job creations (4056)
Job search strategy (1506)
JPM (56)
Kidney cancer (15)
Labor market (83)
Layoffs (566)
Leadership (32)
Legal (8506)
Liver cancer (95)
Longevity (15)
Lung cancer (658)
Lymphoma (374)
Machine learning (43)
Management (59)
Manufacturing (795)
MASH (166)
Medical device (14786)
Medtech (14841)
Mergers & acquisitions (20715)
Metabolic disorders (1303)
Multiple sclerosis (157)
NASH (16)
Neurodegenerative disease (326)
Neuropsychiatric disorders (91)
Neuroscience (2977)
Neurotech (1)
NextGen: Class of 2026 (6919)
Non-profit (4769)
Now hiring (65)
Obesity (616)
Opinion (274)
Ovarian cancer (166)
Pain (202)
Pancreatic cancer (228)
Parkinson's disease (290)
Partnered (34)
Patents (492)
Patient recruitment (482)
Peanut (57)
People (61724)
Pharmaceutical (68)
Pharmacy benefit managers (30)
Phase 1 (22265)
Phase 2 (31386)
Phase 3 (23458)
Pipeline (5139)
Policy (287)
Postmarket research (2742)
Preclinical (9480)
Press Release (67)
Prostate cancer (242)
Psychedelics (49)
Radiopharmaceuticals (287)
Rare diseases (840)
Real estate (6352)
Recruiting (69)
Regulatory (25907)
Reports (51)
Research institute (2548)
Resumes & cover letters (361)
Rett syndrome (27)
RNA editing (16)
RSV (79)
Schizophrenia (154)
Series A (243)
Series B (189)
Service/supplier (12)
Sickle cell disease (98)
Special edition (21)
Spinal muscular atrophy (162)
Sponsored (43)
Startups (3867)
State (2)
Stomach cancer (18)
Supply chain (108)
Tariffs (87)
The Weekly (58)
Vaccines (1034)
Venture capital (89)
Weight loss (410)
Women's health (90)
Worklife (18)
Date
Today (2)
Last 7 days (602)
Last 30 days (1987)
Last 365 days (30442)
2026 (2885)
2025 (30910)
2024 (36106)
2023 (41145)
2022 (52383)
2021 (57101)
2020 (55911)
2019 (48795)
2018 (36938)
2017 (33746)
2016 (33564)
2015 (39609)
2014 (33324)
2013 (28558)
2012 (30846)
2011 (31551)
2010 (29924)
Location
Africa (813)
Alabama (85)
Alaska (7)
Arizona (314)
Arkansas (14)
Asia (42413)
Australia (6984)
California (11278)
Canada (3271)
China (1128)
Colorado (486)
Connecticut (490)
Delaware (339)
Europe (92182)
Florida (1676)
Georgia (364)
Hawaii (3)
Idaho (65)
Illinois (908)
India (63)
Indiana (522)
Iowa (22)
Japan (425)
Kansas (128)
Kentucky (40)
Louisiana (27)
Maine (72)
Maryland (1419)
Massachusetts (8150)
Michigan (330)
Minnesota (645)
Mississippi (6)
Missouri (127)
Montana (31)
Nebraska (28)
Nevada (126)
New Hampshire (84)
New Jersey (3021)
New Mexico (30)
New York (2984)
North Carolina (1519)
North Dakota (8)
Northern California (5481)
Ohio (331)
Oklahoma (21)
Oregon (42)
Pennsylvania (2275)
Puerto Rico (22)
Rhode Island (49)
South America (1196)
South Carolina (67)
South Dakota (1)
Southern California (4391)
Tennessee (175)
Texas (1757)
United States (40367)
Utah (338)
Vermont (1)
Virginia (262)
Washington D.C. (84)
Washington State (949)
West Virginia (4)
Wisconsin (114)
Wyoming (2)
759,356 Results for "microbot medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Microbot Medical Continues its 2025 Momentum; Announces Key 2026 Milestones
January 13, 2026
·
6 min read
Press Releases
Microbot Medical® to Leverage Current Users Experience of the LIBERTY® Endovascular Robotic System at Key Oncology Conference to Support Commercial Adoption
February 5, 2026
·
4 min read
Press Releases
Microbot Medical® to Commercially Debut the LIBERTY® System at The Symposium on Clinical Interventional Oncology Annual Meeting
October 17, 2025
·
5 min read
Press Releases
Microbot Medical® Receives First Patent in Japan as it Continues to Broaden its Global Intellectual Property Portfolio
October 2, 2025
·
3 min read
Press Releases
Microbot Medical® Secures U.S. Based Logistics Partner to Support the Commercialization of Its LIBERTY® Endovascular Robotic System
October 15, 2025
·
3 min read
Press Releases
Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for Up to $92.2 Million in Gross Proceeds
September 16, 2025
·
6 min read
Press Releases
Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic System
September 9, 2025
·
5 min read
Press Releases
Microbot Medical® Granted U.S. Patent that Significantly Expands Potential Market Applications
August 21, 2025
·
4 min read
Press Releases
Microbot Medical Strengthens Global IP Portfolio with Newly Granted Patent in China
June 18, 2025
·
4 min read
Press Releases
Microbot Medical® to Open Inaugural Endovascular Robotics Session at the Society of Robotic Surgery Annual Meeting
July 9, 2025
·
4 min read
1 of 75,936
Next
